FAKTOR OPTIONSSCHEIN - MERCK & CO. Share Price

Certificat

DE000UH2L142

Delayed Deutsche Boerse AG 09:54:20 26/06/2024 pm IST
19.41 EUR +0.99% Intraday chart for FAKTOR OPTIONSSCHEIN - MERCK & CO.
Current month+35.45%
1 month+11.87%
Date Price Change
26/24/26 19.41 +0.99%
25/24/25 19.22 +2.89%
24/24/24 18.68 +10.01%
21/24/21 16.98 +0.89%
20/24/20 16.83 +8.86%

Delayed Quote Deutsche Boerse AG

Last update June 26, 2024 at 09:54 pm IST

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying MERCK & CO., INC.
Issuer UBS
WKN UH2L14
ISINDE000UH2L142
Date issued 13/09/2021
Strike 106.3 $
Maturity Unlimited
Parity 1.29 : 1
Emission price 4.85
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 21.64
Lowest since issue 3.02
Spread 0.3
Spread %1.54%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
132.9 USD
Average target price
142.7 USD
Spread / Average Target
+7.34%
Consensus